UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 504.


Abi-Rached, L; Jobin, MJ; Kulkarni, S; McWhinnie, A; Dalva, K; Gragert, L; Babrzadeh, F; (2011) The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans. SCIENCE , 334 (6052) pp. 89-94. 10.1126/science.1209202.

Agostinelli, C; Hartmann, S; Klapper, W; Korkolopoulou, P; Righi, S; Marafioti, T; Piccaluga, PP; (2011) Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive. HISTOPATHOLOGY , 59 (4) pp. 679-691. 10.1111/j.1365-2559.2011.03981.x.

Aguilera, R; Saffie, C; Tittarelli, A; Gonzalez, FE; Ramirez, M; Reyes, D; Pereda, C; (2011) Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells. CLIN CANCER RES , 17 (8) 2474 - 2483. 10.1158/1078-0432.CCR-10-2384.

Aitchison, KL; Rahim, AA; Hughes, DA; Kinnon, C; Waddington, SN; Howe, SJ; (2011) Lentiviral vectors for gene therapy of Type I Gaucher Disease. HUM GENE THER , 22 (10) A44 - A44.

Akers, NK; Curry, JD; Conde, L; Bracci, PM; Smith, MT; Skibola, CF; (2011) Association of HLA-DQB1 alleles with risk of follicular lymphoma. Leuk Lymphoma , 52 (1) pp. 53-58. 10.3109/10428194.2010.532888.

Albanyan, AA; Albanyan, A; Curry, B; Dragovic, R; Gardiner, C; Biggerstaff, J; Murphy, M; (2011) Measurement of procoagulant microvesicles generated within ageing platelet concentrates. In: (pp. pp. 62-63).

Aleman, MM; Gardiner, C; Harrison, P; Wolberg, AS; (2011) Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost , 9 (11) pp. 2251-2261. 10.1111/j.1538-7836.2011.04488.x.

Allay, JA; Sleep, S; Long, S; Tillman, DM; Clark, R; Carney, G; Fagone, P; (2011) Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial. HUM GENE THER , 22 (5) 595 - 604. 10.1089/hum.2010.202.

Alvarez-Erviti, L; Seow, Y; Schapira, AH; Gardiner, C; Sargent, IL; Wood, MJA; Cooper, JM; (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. NEUROBIOL DIS , 42 (3) 360 - 367. 10.1016/j.nbd.2011.01.029. Gold open access

Amary, MF; Bacsi, K; Maggiani, F; Damato, S; Halai, D; Berisha, F; Pollock, R; (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J PATHOL , 224 (3) 334 - 343. 10.1002/path.2913.

Amary, MF; Damato, S; Halai, D; Eskandarpour, M; Berisha, F; Bonar, F; McCarthy, S; (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet , 43 (12) pp. 1262-1265. 10.1038/ng.994.

Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, Y; Colman, SM; Kempski, H; (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. NATURE , 469 (7330) 356-+. 10.1038/nature09650.

Andrady, C; Sharma, SK; Chester, KA; (2011) Antibody-enzyme fusion proteins for cancer therapy. IMMUNOTHERAPY-UK , 3 (2) 193 - 211. 10.2217/IMT.10.90.

Anoop, P; Shaw, BE; Riley, U; Ethell, ME; Taj, M; Lancaster, DL; Atra, A; (2011) Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. HEMATOLOGY , 16 (4) 213 - 220. 10.1179/102453311X13025568941763.

Arce, F; Breckpot, K; Collins, M; Escors, D; (2011) Targeting lentiviral vectors for cancer immunotherapy. Curr Cancer Ther Rev , 7 (4) pp. 248-260. 10.2174/157339411797642605. Green open access

Arce, F; Breckpot, K; Stephenson, H; Karwacz, K; Ehrenstein, MR; Collins, M; Escors, D; (2011) Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis. ARTHRITIS RHEUM-US , 63 (1) 84 - 95. 10.1002/art.30099.

Arkenau, HK; (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? Ann Oncol , 22 (1) pp. 239-240. 10.1093/annonc/mdq676.

Arkenau, HT; Kefford, R; Long, GV; (2011) Targeting BRAF for patients with melanoma. Br J Cancer , 104 (3) pp. 392-398. 10.1038/sj.bjc.6606030.

Arkenau, HT; Nordman, I; Dobbins, T; Ward, R; (2011) Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer. Cancer , 117 (4) pp. 832-840. 10.1002/cncr.25636.

Arrieta Bolanos, ER; Maldonado-Torres, H; Dimitriu, O; Hoddinott, MA; Fowles, F; Shah, A; Órlich-Pérez, P; (2011) HLA-A, -B, -C, -DQB1, and -DRB1,3,4,5 allele and haplotype frequencies in the Costa Rica Central Valley Population and its relationship to worldwide populations. Human Immunology , 72 (1) pp. 80-86. 10.1016/j.humimm.2010.10.005.

Arthold, S; Kurowski, A; Wutz, A; (2011) Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet , 130 (2) pp. 295-305. 10.1007/s00439-011-1002-0.

Averbuch, D; Chapgier, A; Boisson-Dupuis, S; Casanova, JL; Engelhard, D; (2011) The clinical spectrum of patients with deficiency of Signal Transducer and Activator of Transcription-1. Pediatr Infect Dis J , 30 (4) pp. 352-355. 10.1097/INF.0b013e3181fdff4a.

Ayto, RM; Reed, M; Baker, R; Steele, AJ; Wickremasinghe, RG; Mehta, AB; Hughes, DA; (2011) Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 16). WILEY-BLACKWELL


Babu, B; Lee, M; Lee, L; Strobel, R; Brockway, O; Nickols, A; Sjoholm, R; (2011) Acetyl analogs of combretastatin A-4: Synthesis and biological studies. BIOORGAN MED CHEM , 19 (7) 2359 - 2367. 10.1016/j.bmc.2011.02.018.

Babu, B; Liu, Y; Plaunt, A; Riddering, C; Ogilvie, R; Westrate, L; Davis, R; (2011) Design, synthesis and DNA binding properties of orthogonally positioned diamino containing polyamide f-IPI. BIOCHEM BIOPH RES CO , 404 (3) 848 - 852. 10.1016/j.bbrc.2010.12.073.

Babu, B; Ramos, J; Liu, Y; Chavda, S; Tzou, S; Brockway, O; Sjoholm, R; (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Ball, J; Cohen, H; Knowles, S; (2011) A retrospective audit of fluid balance recording in transfusion associated circulatory overload (TACO) reports analysed by the serious hazards of transfusion 9SHOT) scheme. In: (Proceedings) British Blood Transfusion Society.

Ballingall, KT; Herrmann-Hoesing, L; Robinson, J; Marsh, SGE; Stear, MJ; (2011) A single nomenclature and associated database for alleles at the major histocompatibility complex class II DRB1 locus of sheep. TISSUE ANTIGENS , 77 (6) pp. 546-553. 10.1111/j.1399-0039.2011.01637.x.

Banks, MR; Haidry, R; Butt, MA; Whitley, L; Stein, J; Langmead, L; Bloom, SL; (2011) High resolution colonoscopy in a bowel cancer screening program improves polyp detection. WORLD JOURNAL OF GASTROENTEROLOGY , 17 (38) pp. 4308-4313. 10.3748/wjg.v17.i38.4308. Gold open access

Baraniskin, A; Munding, J; Schulmann, K; Meier, D; Porschen, R; Arkenau, HT; Graeven, U; (2011) Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. Clin Colorectal Cancer , 10 (1) pp. 24-29. 10.3816/CCC.2011.n.003.

Barton, S; Swanton, C; (2011) Recent developments in treatment stratification for metastatic breast cancer. Drugs , 71 (16) pp. 2099-2113. 10.2165/11594480-000000000-00000.

Bateman, A; Agrawal, S; Birney, E; Bruford, EA; Bujnicki, JM; Cochrane, G; Cole, JR; (2011) RNAcentral: A vision for an international database of RNA sequences. RNA , 17 (11) pp. 1941-1946. 10.1261/rna.2750811.

Bates, AW; (2011) The anatomy of beauty in nineteenth-century England. Hektoen International , 3 (1)

Bell, CG; (2011) Accessing and selecting genetic markers from available resources. Methods Mol Biol , 760 pp. 1-17. 10.1007/978-1-61779-176-5_1.

Beltran, L; Chaussade, C; Vanhaesebroeck, B; Cutillas, PR; (2011) Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity. Proc Natl Acad Sci U S A , 108 (39) pp. 16217-16222. 10.1073/pnas.1107692108.

Bennett, CL; Fallah-Arani, F; Conlan, T; Trouillet, C; Goold, H; Chorro, L; Flutter, B; (2011) Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. BLOOD , 117 (26) 7063 - 7069. 10.1182/blood-2011-01-329185.

Bennett, K; James, C; Mutair, A; Al-Shaikh, H; Sinani, A; Hussain, K; (2011) Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene. PEDIATRIC DIABETES , 12 (3) pp. 192-196. 10.1111/j.1399-5448.2010.00683.x.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; Buckley, S; (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Birkbak, NJ; Eklund, AC; Li, Q; McClelland, SE; Endesfelder, D; Tan, P; Tan, IB; (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res , 71 (10) pp. 3447-3452. 10.1158/0008-5472.CAN-10-3667.

Bjedov, I; Partridge, L; (2011) A longer and healthier life with TOR down-regulation: genetics and drugs. In: BIOCHEMICAL SOCIETY TRANSACTIONS. (pp. 460 - 465). PORTLAND PRESS LTD

Blanc, V; Nariculam, J; Munson, P; Freeman, A; Klocker, H; Masters, J; Williamson, M; (2011) A Role for Class 3 Semaphorins in Prostate Cancer. PROSTATE , 71 (6) pp. 649-658. 10.1002/pros.21281.

Bolli, N; Payne, EM; Rhodes, J; Gjini, E; Johnston, AB; Guo, F; Lee, JS; (2011) cpsf1 is required for definitive HSC survival in zebrafish. Blood , 117 (15) pp. 3996-4007. 10.1182/blood-2010-08-304030.

Boo, M; van Walraven, SM; Chapman, J; Lindberg, B; Schmidt, AH; Shaw, BE; Switzer, GE; (2011) Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. BLOOD , 117 (1) 21 - 25. 10.1182/blood-2010-07-298430.

Boshoff, C; (2011) Unraveling virus-induced lymphomagenesis. J CLIN INVEST , 121 (3) 838 - 841. 10.1172/JCI46499. Gold open access

Bouma, G; Mendoza-Naranjo, A; Blundell, MP; de Falco, E; Parsley, KL; Burns, SO; Thrasher, AJ; (2011) Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. BLOOD , 118 (9) 2492 - 2501. 10.1182/blood-2011-03-340265.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? Nephrol Dial Transplant , 26 (2) pp. 742-744. 10.1093/ndt/gfq644.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? NEPHROL DIAL TRANSPL , 26 (2) 742 - 744. 10.1093/ndt/gfq644.

Bridgewater, JA; Stubbs, C; Primrose, JN; National Cancer Research Institute (UK) Upper Gastrointestinal S, ; (2011) BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer. J Clin Oncol , 29 (15_suppl) 4125-.

Briesemeister, D; Sommermeyer, D; Loddenkemper, C; Loew, R; Uckert, W; Blankenstein, T; Kammertoens, T; (2011) Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. INT J CANCER , 128 (2) 371 - 378. 10.1002/ijc.25350.

Brough, R; Frankum, JR; Sims, D; Mackay, A; Mendes-Pereira, AM; Bajrami, I; Costa-Cabral, S; (2011) Functional viability profiles of breast cancer. Cancer Discov , 1 (3) pp. 260-273. 10.1158/2159-8290.CD-11-0107.

Brown, NF; Marks, DJ; Smith, PJ; Bloom, SL; (2011) Splenomegaly. Br J Hosp Med (Lond) , 72 (11) M166-M169.

Brucoli, F; Hawkins, RM; James, CH; Wells, G; Jenkins, TC; Ellis, T; Hartley, JA; (2011) Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. BIOORG MED CHEM LETT , 21 (12) 3780 - 3783. 10.1016/j.bmcl.2011.04.054.

Brunetto, A; Olmos, D; Arkenau, HT; Tan, D; Yap, T; de Bono, J; Barriuso, J; (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401-. 10.1155/2011/861401.

Bustamante, J; Arias, AA; Vogt, G; Picard, C; Galicia, LB; Prando, C; Grant, AV; (2011) Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol , 12 (3) pp. 213-221. 10.1038/ni.1992.


Calabretta, B; Salomoni, P; (2011) Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. LEUKEMIA LYMPHOMA , 52 54 - 59. 10.3109/10428194.2010.546913.

Calleja-Agius, J; Muttukrishna, S; Pizzey, AR; Jauniaux, E; (2011) Pro- and antiinflammatory cytokines in threatened miscarriages. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , 205 (1) 10.1016/j.ajog.2011.02.051.

Calvert, H; Azzariti, A; (2011) The clinical development of inhibitors of poly(ADP-ribose) polymerase. ANNALS OF ONCOLOGY , 22 i53 - i59. 10.1093/annonc/mdq667.

Cantu, C; Ierardi, R; Alborelli, I; Fugazza, C; Cassinelli, L; Piconese, S; Bose, F; (2011) Sox6 enhances erythroid differentiation in human erythroid progenitors. BLOOD , 117 (13) pp. 3669-3679. 10.1182/blood-2010-04-282350.

Cappellini, MD; Bejaoui, M; Agaoglu, L; Canatan, D; Capra, M; Cohen, A; Drelichman, G; (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. BLOOD , 118 (4) 884 - 893. 10.1182/blood-2010-11-316646.

Carpenter, JP; He, T; Kirk, P; Roughton, M; Anderson, LJ; de Noronha, SV; Sheppard, MN; (2011) On T2* magnetic resonance and cardiac iron. Circulation , 123 (14) pp. 1519-1528. 10.1161/CIRCULATIONAHA.110.007641.

Carpenter, L; Malladi, R; Yang, C-T; French, A; Pilkington, KJ; Forsey, RW; Sloane-Stanley, J; (2011) Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. BLOOD , 117 (15) pp. 4008-4011. 10.1182/blood-2010-08-299941.

Carrera-Marin, AL; Romay-Penabad, Z; Machin, S; Cohen, H; Weston-Davies, W; Pierangeli, SS; (2011) C5 Inhibitor rEV576 Ameliorates In Vivo Effects of Antiphospholipid Antibodies. In: (Proceedings) 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S5-S5). WILEY-BLACKWELL

Carrera-Marin, AL; Romay-Penabad, Z; Weston-Davis, W; Machin, S; Cohen, H; Pierangeli, SS; (2011) C5 inhibitor rEV576 ameliorates in vivo effects of antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 290.

Catlin, SN; Busque, L; Gale, RE; Guttorp, P; Abkowitz, JL; (2011) The replication rate of human hematopoietic stem cells in vivo. BLOOD , 117 (17) 4460 - 4466. 10.1182/blood-2010-08-303537.

Cerone, MA; Burgess, DJ; Naceur-Lombardelli, C; Lord, CJ; Ashworth, A; (2011) High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res , 71 (9) pp. 3328-3340. 10.1158/0008-5472.CAN-10-2734.

Chakraverty, R; Mackinnon, S; (2011) Allogeneic Transplantation for Lymphoma. J CLIN ONCOL , 29 (14) 1855 - 1863. 10.1200/JCO.2010.32.8419.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; (2011) Hx, a Novel Fluorescent, Minor Groove and Sequence Specific Recognition Element: Design, Synthesis, and DNA Binding Properties of p-Anisylbenzimidazole-imidazole/pyrrole-Containing Polyamides. BIOCHEMISTRY-US , 50 (15) 3127 - 3136. 10.1021/bi102028a.

Cheng, F; Pekkonen, P; Laurinavicius, S; Sugiyama, N; Henderson, S; Guenther, T; Rantanen, V; (2011) KSHV-Initiated Notch Activation Leads to Membrane-Type-1 Matrix Metalloproteinase-Dependent Lymphatic Endothelial-to-Mesenchymal Transition. CELL HOST & MICROBE , 10 (6) pp. 577-590. 10.1016/j.chom.2011.10.011.

Chew, SK; Rad, R; Futreal, PA; Bradley, A; Liu, P; (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) pp. 366-371. 10.1016/j.ymeth.2010.12.022.

Chua, MLK; Somaiah, N; A'Hern, R; Davies, S; Gothard, L; Yarnold, J; Rothkamm, K; (2011) Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy. RADIOTHER ONCOL , 99 (3) 362 - 366. 10.1016/j.radonc.2011.05.071.

Chua, MLK; Somaiah, N; Bourne, S; Daley, F; A'Hern, R; Nuta, O; Davies, S; (2011) Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. RADIOTHER ONCOL , 99 (2) 225 - 230. 10.1016/j.radonc.2011.04.009.

Cohen, H; (2011) Current best practice in oral anticoagulation. In: (Proceedings) Sysmex user symposium.

Cohen, H; (2011) Heritable thrombotic risk factors: influence on antiphospholipid syndrome pregnancy outcomes and treatment in pregnancy. Presented at: VIII European Forum on antiphospholipid antibodies, Padua.

Cohen, H; (2011) Heritable thrombotic risk factors: influence on antiphospholipid syndrome pregnancy outcomes and treatment in pregnancy. Presented at: VIII European Forum on antiphospholipid antibodies, Padua.

Cohen, H; (2011) New oral anticoagulants in antiphospholipid syndrome: the RAPS trisl. [Lecture]. Presented at: APS ACTION 2nd annual summit, Chicago.

Cohen, H; (2011) Placental vascular mediated late obstetric morbidity: management and outcomes. [Lecture]. Presented at: British society for haematology obstetric subgroup, Leicester.

Cohen, H; (2011) SHOT 2010 and improving patient safety through interventions based on SHOT data. [Lecture]. Presented at: SHOT annual symposium, London.

Conde, L; Bevan, S; Sitzer, M; Klopp, N; Illig, T; Thiery, J; Seissler, J; (2011) Novel associations for coronary artery disease derived from genome wide association studies are not associated with increased carotid intima-media thickness, suggesting they do not act via early atherosclerosis or vessel remodeling. Atherosclerosis , 219 (2) pp. 684-689. 10.1016/j.atherosclerosis.2011.08.031.

Conde, L; Bracci, PM; Halperin, E; Skibola, CF; (2011) A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases. Genomics , 98 (1) pp. 9-14. 10.1016/j.ygeno.2011.03.007.

Confer, DL; Shaw, BE; Pamphilon, DH; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. Bone Marrow Transplantation , 46 (11) pp. 1409-1412. 10.1038/bmt.2010.323.

Confer, DL; Shaw, BE; Pamphilon, DH; Clinical Working Grp WMDA, ; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. BONE MARROW TRANSPL , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

Conrad, DF; Keebler, JE; DePristo, MA; Lindsay, SJ; Zhang, Y; Casals, F; Idaghdour, Y; (2011) Variation in genome-wide mutation rates within and between human families. Nat Genet , 43 (7) pp. 712-714. 10.1038/ng.862.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Downstream of human NDR kinases Impacting on c-myc and p21 protein stability to control cell cycle progression. CELL CYCLE , 10 (12) 1897 - 1904. 10.4161/cc.10.12.15826.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Human NDR Kinases Control G(1)/S Cell Cycle Transition by Directly Regulating p21 Stability. MOL CELL BIOL , 31 (7) 1382 - 1395. 10.1128/MCB.01216-10.

Cortese, R; Lewin, J; Backdahl, L; Krispin, M; Wasserkort, R; Eckhardt, F; Beck, S; (2011) Genome-Wide Screen for Differential DNA Methylation Associated with Neural Cell Differentiation in Mouse. PLOS ONE , 6 (10) , Article e26002. 10.1371/journal.pone.0026002. Green open access

Counsell, N; Cortina-Borja, M; Lehtonen, A; Stein, A; (2011) Modelling psychiatric measures using Skew-Normal distributions. EUR PSYCHIAT , 26 (2) 112 - 114. 10.1016/j.eurpsy.2010.08.006.

Coward, J; Kulbe, H; Chakravarty, P; Leader, D; Vassileva, V; Leinster, DA; Thompson, R; (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. CLINICAL CANCER RESEARCH , 17 (18) pp. 6083-6096. 10.1158/1078-0432.CCR-11-0945.

Cox, S.T.; (2011) The relevance and impact of MICA allele mismatching and MICA antibodies on renal transplantation outcome. Doctoral thesis, UCL (University College London). Green open access

Cox, ST; Stephens, HA; Fernando, R; Karasu, A; Harber, M; Howie, AJ; Powis, S; (2011) Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol , 72 (10) pp. 827-834. 10.1016/j.humimm.2011.05.004.

Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S; (2011) Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition. J BIOL CHEM , 286 (11) 9713 - 9725. 10.1074/jbc.M110.173872. Gold open access


Dancey, G.S.; (2011) Novel radioimmunotherapy for lymphoma and solid tumours both as a single agent and in combination with the vascular disrupting agents. Doctoral thesis, UCL (University College London). Green open access

Danecek, P; Auton, A; Abecasis, G; Albers, CA; Banks, E; DePristo, MA; Handsaker, RE; (2011) The variant call format and VCFtools. Bioinformatics , 27 (15) pp. 2156-2158. 10.1093/bioinformatics/btr330.

David, AL; McIntosh, J; Peebles, DM; Cook, T; Waddington, S; Weisz, B; Wigley, V; (2011) Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep. HUM GENE THER , 22 (4) 419 - 426. 10.1089/hum.2010.007.

Davies, T; Poles, D; Watt, A; Ball, J; Mistry, H; Knowles, S; Cohen, H; (2011) SHOT participation and benchmarking data 2010. In: (Proceedings) British Blood Transfusion Society.

De, S; Varsally, W; Falciani, F; Brogna, S; (2011) Ribosomal proteins' association with transcription sites peaks at tRNA genes in Schizosaccharomyces pombe. RNA , 17 (9) pp. 1713-1726. 10.1261/rna.2808411.

De Bono, JS; Logothetis, CJ; Molina, A; Fizazi, K; North, S; Chu, L; Chi, KN; (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. NEW ENGLAND JOURNAL OF MEDICINE , 364 (21) pp. 1995-2005.

De Gobbi, M; Garrick, D; Lynch, M; Vernimmen, D; Hughes, JR; Goardon, N; Luc, S; (2011) Generation of bivalent chromatin domains during cell fate decisions. EPIGENETICS & CHROMATIN , 4 (ARTN 9) 10.1186/1756-8935-4-9. Gold open access

Dedes, KJ; Wetterskog, D; Ashworth, A; Kaye, SB; Reis-Filho, JS; (2011) Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol , 8 (5) pp. 261-271. 10.1038/nrclinonc.2010.216.

Dedes, KJ; Wilkerson, PM; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, JS; (2011) Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle , 10 (8) pp. 1192-1199. 10.4161/cc.10.8.15273.

Della Peruta, M; Binny, C; Nathwani, D; Chokshi, S; McIntosh, J; Rosales, C; Davidoff, AM; (2011) The development of a tumour-selective recombinant adeno-associated virus vector to target hepatocellular carcinoma. HUMAN GENE THERAPY , 22 (10) A113 - A113.

Deltcheva, E; Chylinski, K; Sharma, CM; Gonzales, K; Chao, Y; Pirzada, ZA; Eckert, MR; (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature , 471 (7340) pp. 602-607. 10.1038/nature09886.

Denbo, JW; Williams, RF; Orr, WS; Sims, TL; Ng, CY; Zhou, JF; Spence, Y; (2011) Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model. SURGERY , 150 (3) 497 - 504. 10.1016/j.surg.2011.07.044.

Deugnier, Y; Turlin, B; Ropert, M; Cappellini, MD; Porter, JB; Giannone, V; Zhang, Y; (2011) Improvement in Liver Pathology of Patients With beta-Thalassemia Treated With Deferasirox for at Least 3 Years. GASTROENTEROLOGY , 141 (4) 1202-U618. 10.1053/j.gastro.2011.06.065.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) The danger to cytopathology of over-specialization and its relevance for histopathology. CYTOPATHOLOGY , 22 (2) 140 - 140. 10.1111/j.1365-2303.2011.00865.x.

Doebroessy, M; Klein, A; Janghra, N; Nikkhah, G; Dunnett, SB; (2011) Validating the use of M4-BAC-GFP mice as tissue donors in cell replacement therapies in a rodent model of Huntington's disease. JOURNAL OF NEUROSCIENCE METHODS , 197 (1) pp. 6-13. 10.1016/j.jneumeth.2011.01.015.

Donaldson, J; Khan, WS; Tailor, H; Hughes, DA; Mehta, AB; Maruthainar, N; (2011) Gaucher disease: outcome following total hip replacements and effect of enzyme replacement therapy in a cohort of UK patients. HIP INTERNATIONAL , 21 (6) pp. 665-671. 10.5301/HIP.2011.8826.

Dragovic, RA; Gardiner, C; Brooks, AS; Tannetta, DS; Ferguson, DJ; Hole, P; Carr, B; (2011) Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine , 7 (6) pp. 780-788. 10.1016/j.nano.2011.04.003.

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 2). WILEY-BLACKWELL

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (pp. p. 2).

Drebes, AB; Khalil, A; O'Brien, P; Cohen, H; (2011) Late obstetric morbidity in women with and without inherited or acquired thrombophilia: management and outcomes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 631.

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; Rea, D; (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. J Clin Oncol , 29 (15_suppl) 3104-.

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; Rea, D; (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Duarte, RF; Shaw, BE; Marin, P; Kottaridis, P; Ortiz, M; Morante, C; Delgado, J; (2011) Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. BONE MARROW TRANSPL , 46 (1) 52 - 58. 10.1038/bmt.2010.54.

Dudderidge, TJ; Kelly, J; Wollenschlaeger, A; Leung, H; Okoturo, O; Prevost, T; Prevost, T; (2011) DIAGNOSIS OF BLADDER CANCER BY COMBINED DETECTION OF MINICHROMOSOME MAINTENANCE 5 PROTEIN AND NMP22 IN URINE. EUR UROL SUPPL , 10 (2) 73 - 74.

Duhamel, L.A.E.; (2011) The role of LKB1 in the pathogenesis of Osteosarcoma. Doctoral thesis, UCL (University College London). Green open access

Dunn, JM; Banks, MR; Oukrif, D; Mackenzie, GD; Thorpe, S; Rodriguez-Justo, M; Winstanley, A; (2011) Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy. ENDOSCOPY , 43 (7) 627 - 630. 10.1055/s-0030-1256443.

Dunn, JM; Hveem, T; Pretorius, M; Oukrif, D; Nielsen, B; Albregtsen, F; Lovat, LB; (2011) Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus. BRIT J CANCER , 105 (8) 1218 - 1223. 10.1038/bjc.2011.353.

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Rodriguez-Justo, M; (2011) A Randomised Controlled Trial of ALA V Photofrin PDT for High Grade Dysplasia in Barrett's Esophagus. In: GASTROENTEROLOGY. (pp. S215 - S216). W B SAUNDERS CO-ELSEVIER INC





El-Sharkawi, D; Ramsay, A; Cwynarski, K; Hughes, D; Prentice, A; Davies, N; Goode, A; (2011) Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques. LEUKEMIA LYMPHOMA , 52 (11) 2130 - 2134. 10.3109/10428194.2011.589546.

Elliott, P; Baker, R; Pasquale, F; Quarta, G; Ebrahim, H; Mehta, AB; Hughes, DA; (2011) Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. HEART , 97 (23) 1957 - 1960. 10.1136/heartjnl-2011-300364.

Endesfelder, D; McGranahan, N; Birkbak, NJ; Szallasi, Z; Kschischo, M; Graham, TA; Swanton, C; (2011) A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables. ONCOTARGET , 2 (7) pp. 529-537.

Ertemi, H; Mumtaz, FH; Howie, AJ; Mikhailidis, DP; Thompson, CS; (2011) Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated Relaxation. J UROLOGY , 185 (6) 2414 - 2420. 10.1016/j.juro.2011.02.2645.

Escors, D; Bricogne, C; Arce, F; Kochan, G; Karwacz, K; (2011) On the Mechanism of T cell receptor down-modulation and its physiological significance. J Biosci Med , 1 (1)

Evans, IM; Yamaji, M; Britton, G; Pellet-Many, C; Lockie, C; Zachary, IC; Frankel, P; (2011) Neuropilin-1 Signaling through p130(Cas) Tyrosine Phosphorylation Is Essential for Growth Factor-Dependent Migration of Glioma and Endothelial Cells. MOLECULAR AND CELLULAR BIOLOGY , 31 (6) pp. 1174-1185. 10.1128/MCB.00903-10.

Evans, P; Cindrova-Davies, T; Muttukrishna, S; Burton, GJ; Porter, J; Jauniaux, E; (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. MOL HUM REPROD , 17 (4) 227 - 232. 10.1093/molehr/gaq101.


Faelber, K; Posor, Y; Gao, S; Held, M; Roske, Y; Schulze, D; Haucke, V; (2011) Crystal structure of nucleotide-free dynamin. Nature , 477 (7366) pp. 556-560. 10.1038/nature10369.

Feber, A; Wilson, GA; Zhang, L; Presneau, N; Idowu, B; Down, TA; Rakyan, VK; (2011) Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Research , 21 (4) pp. 515-524. 10.1101/gr.109678.110. Gold open access

Feber, A; Xi, LQ; Pennathur, A; Gooding, WE; Bandla, S; Wu, MX; Luketich, JD; (2011) MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal Adenocarcinoma. ANNALS OF THORACIC SURGERY , 91 (5) 1523 - 1530. 10.1016/j.athoracsur.2011.01.056.

Feng, G; Nadig, SN; Backdahl, L; Beck, S; Francis, RS; Schiopu, A; Whatcott, A; (2011) Functional Regulatory T Cells Produced by Inhibiting Cyclic Nucleotide Phosphodiesterase Type 3 Prevent Allograft Rejection. SCI TRANSL MED , 3 (83) , Article 83ra40. 10.1126/scitranslmed.3002099.

Feng, H; Hu, B; Liu, KW; Li, Y; Lu, X; Cheng, T; Yiin, JJ; (2011) Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest , 121 (12) pp. 4670-4684. 10.1172/JCI58559.

Fenton, TR; Gout, IT; (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY , 43 (1) pp. 47-59. 10.1016/j.bioce1.2010.09.018.

Fernandes, E; Goold, HD; Kissenpfennig, A; Malissen, B; Dyson, J; Bennett, CL; (2011) The Role of Direct Presentation by Donor Dendritic Cells in Rejection of Minor Histocompatibility Antigen-Mismatched Skin and Hematopoietic Cell Grafts. TRANSPLANTATION , 91 (2) 154 - 160. 10.1097/TP.0b013e318201ac27.

Ferrer, IR; Araki, K; Ford, ML; (2011) Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transplant , 11 (4) pp. 654-659. 10.1111/j.1600-6143.2011.03473.x.

Ferrer, IR; Wagener, ME; Song, M; Kirk, AD; Larsen, CP; Ford, ML; (2011) Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A , 108 (51) pp. 20701-20706. 10.1073/pnas.1105500108.

Fielding, AK; (2011) Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA , 25 (6) 1255-+. 10.1016/j.hoc.2011.09.008.

Fielding, AK; (2011) Current Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM pp. 231-237. 10.1182/asheducation-2011.1.231.

Fielding, AK; (2011) Philadelphia-Positive Acute Lymphoblastic Leukemia-Is Bone Marrow Transplant Still Necessary? BIOL BLOOD MARROW TR , 17 (1) S84 - S88. 10.1016/j.bbmt.2010.11.023.

Fisher, R; Larkin, J; Swanton, C; (2011) Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity. EPMA J , 3 (1) 1-. 10.1007/s13167-011-0137-3.

Flicek, P; Amode, MR; Barrell, D; Beal, K; Brent, S; Chen, Y; Clapham, P; (2011) Ensembl 2011. Nucleic Acids Res , 39 (Database) D800-D806. 10.1093/nar/gkq1064.

Flutter, B; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced Co-Stimulation and Co-Inhibitory Blockade Synergize to Enhance the Functions of Exhausted CTL. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 833-834). AMER SOC HEMATOLOGY

Flutter, B; Velica, P; Chakraverty, R; (2011) Memory lapses in graft-versus-host disease. EUR J IMMUNOL , 41 (9) 2530 - 2534. 10.1002/eji.201141946.

Flutter, BR; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced co-stimulation and co-inhibitory blockade synergise to enhance the functions of exhausted CTL. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 38). WILEY-BLACKWELL

Foroni, L; Wilson, G; Gerrard, G; Mason, J; Grimwade, D; White, HE; de Castro, DG; (2011) Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 153 (2) pp. 179-190. 10.1111/j.1365-2141.2011.08603.x.

Forster, MD; Dedes, KJ; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, CJ; (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol , 8 (5) pp. 302-306. 10.1038/nrclinonc.2011.42.

Foxall, RB; Albuquerque, AS; Soares, RS; Baptista, AP; Cavaleiro, R; Tendeiro, R; Gomes, P; (2011) Memory and naive-like regulatory CD4+ T cells expand during HIV-2 infection in direct association with CD4+ T-cell depletion irrespectively of viremia. AIDS , 25 (16) pp. 1961-1970. 10.1097/QAD.0b013e32834b3554.

Furniss, D; Blandford, AE; Mayer, A; (2011) Considering Unremarkable Computing for Healthcare. Presented at: Workshop on Interactive Systems in Healthcare (WISH), Workshop at AMIA 2011 Annual Symposium.

Furniss, D; Blandford, AE; Rajkomar, A; Vincent, C; Mayer, A; (2011) The visible and the invisible: Distributed Cognition for medical devices. In: Blandford, A and De Pietro, G and Gallo, L and Gimblett, A and Oladimeji, P and Thimbleby, H, (eds.) EICS4Med 2011: Proceedings of the 1st International Workshop on Engineering Interactive Computing Systems for Medicine and Health Care: Pisa, Italy: June, 2011. (pp. pp. 1-6). CEUR Green open access

Furstenberg, A; Walsh, SB; Howie, A; Jones, G; Unwin, RJ; (2011) Calcineurin-Inhibitor Induced Hypertension, Hyperkalaemia and Metabolic Acidosis Is Caused by Overactivity of the Sodium Chloride Cotransporter. In: AMERICAN JOURNAL OF TRANSPLANTATION. (pp. 406 - 406). WILEY-BLACKWELL

Furuse, J; Okusaka, T; Bridgewater, J; Taketsuna, M; Wasan, H; Koshiji, M; Valle, J; (2011) Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , 80 (1) pp. 31-39. 10.1016/j.critrevonc.2010.10.009.


Gadaleta, RM; Oldenburg, B; Willemsen, EC; Spit, M; Murzilli, S; Salvatore, L; Klomp, LW; (2011) Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine. Biochim Biophys Acta , 1812 (8) pp. 851-858. 10.1016/j.bbadis.2011.04.005.

Gal, A; Hughes, DA; Winchester, B; (2011) Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group. J INHERIT METAB DIS , 34 (2) 509 - 514. 10.1007/s10545-010-9261-9.

Galavotti, S; Shaked-Rabi, M; Tulchinsky, E; Brandner, S; Jones, C; Salomoni, P; (2011) THE METABOLIC AUTOPHAGY PATHWAY REGULATES MIGRATION AND INVASION IN GLIOMA. In: NEURO-ONCOLOGY. (pp. 10 - 10). OXFORD UNIV PRESS INC

García-Gómez, JJ; Babiano, R; Lebaron, S; Froment, C; Monsarrat, B; Henry, Y; de la Cruz, J; (2011) Nop6, a component of 90S pre-ribosomal particles, is required for 40S ribosomal subunit biogenesis in Saccharomyces cerevisiae. RNA Biol , 8 (1) pp. 112-124.

García-Gómez, JJ; Lebaron, S; Froment, C; Monsarrat, B; Henry, Y; de la Cruz, J; (2011) Dynamics of the putative RNA helicase Spb4 during ribosome assembly in Saccharomyces cerevisiae. Mol Cell Biol , 31 (20) pp. 4156-4164. 10.1128/MCB.05436-11.

Gardiner, C; Tannetta, DS; Harrison, P; Redman, CWG; Sargent, IL; (2011) Increased levels of tissue factor activity on syncytiotrophoblast microvesicles released into the maternal circulation during pre-eclampsia. In: (pp. p. 169).

Gardiner, C; Tannetta, DS; Simms, CA; Harrison, P; Redman, CW; Sargent, IL; (2011) Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS One , 6 (10) , Article e26313. 10.1371/journal.pone.0026313.

Germani, G; Hytiroglou, P; Fotiadu, A; Burroughs, AK; Dhillon, AP; (2011) Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An Update. SEMIN LIVER DIS , 31 (1) 82 - 90. 10.1055/s-0031-1272836.

Gerrard, G; Mudge, K; Stewart, R; Foskett, P; Stevens, D; Khorashad, JS; Szydlo, R; (2011) Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies. AMERICAN JOURNAL OF HEMATOLOGY , 86 (3) pp. 313-315. 10.1002/ajh.21954.

Gillmore, R; Stuart, S; Kirkwood, A; Hameeduddin, A; Woodward, N; Burroughs, AK; Meyer, T; (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolisation. JOURNAL OF HEPATOLOGY , 55 (6) pp. 1309-1316.


Goardon, N; Marchi, E; Atzberger, A; Quek, L; Schuh, A; Soneji, S; Woll, P; (2011) Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia. CANCER CELL , 19 (1) pp. 138-152. 10.1016/j.ccr.2010.12.012.

Goh, V; Shastry, M; Engledow, A; Reston, J; Wellsted, DM; Peck, J; Endozo, R; (2011) Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer. Eur Radiol , 21 (4) pp. 744-749. 10.1007/s00330-010-1967-4.

Goldstein, R; Meyer, T; (2011) Role of everolimus in pancreatic neuroendocrine tumors. EXPERT REVIEW OF ANTICANCER THERAPY , 11 (11) pp. 1653-1665. 10.1586/ERA.11.145.

Golubnitschaja, O; Swanton, C; Danesi, R; Costigliola, V; (2011) Promoting predictive, preventive and personalised medicine: European event of global importance. EPMA J , 2 (2) pp. 131-136. 10.1007/s13167-011-0088-8.

Goold, H; Escors, D; Conlan, T; Chakraverty, R; Bennett, CL; (2011) Vaccination with Lentiviral Vectors Responses to a Model Antigen After Cutaneous the Activation of Helper-Dependent CD8 T Cell Conventional Dendritic Cells Are Required for. Journal of Immunology , 186 (8) pp. 4565-4572. 10.4049/jimmunol.1002529.

Goold, HD; Escors, D; Conlan, TJ; Chakraverty, R; Bennett, CL; (2011) Conventional Dendritic Cells Are Required for the Activation of Helper-Dependent CD8 T Cell Responses to a Model Antigen After Cutaneous Vaccination with Lentiviral Vectors. J IMMUNOL , 186 (8) 4565 - 4572. 10.4049/jimmunol.1002529. Gold open access

Grabher, C; Payne, EM; Johnston, AB; Bolli, N; Lechman, E; Dick, JE; Kanki, JP; (2011) Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. LEUKEMIA , 25 (3) pp. 506-514. 10.1038/leu.2010.280.

Graham, TA; Humphries, A; Sanders, T; Rodriguez-Justo, M; Tadrous, PJ; Preston, SL; Novelli, MR; (2011) Use of methylation patterns to determine expansion of stem cell clones in human colon tissue. Gastroenterology , 140 (4) 1241-1250.e1-9-. 10.1053/j.gastro.2010.12.036.

Green, CL; Evans, CM; Zhao, L; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2011) The prognostic significance of IDH2 mutations in AML depends on the location of the mutation. BLOOD , 118 (2) 409 - 412. 10.1182/blood-2010-12-322479.

Green, L; De Lord, C; Clark, B; Cadet, E; Rochette, J; Thein, SL; (2011) Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload. Br J Haematol , 154 (3) 288-. 10.1111/j.1365-2141.2011.08666.x.

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 3). WILEY-BLACKWELL

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (pp. p. 3).

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of an automated thrombin generation assay which is sensitive to defects of protein C pathway. In: J THROMB HAEMOST. (pp. 154 - 154). WILEY-BLACKWELL

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The effect of total hip and knee replacement surgery and dabigatran on thrombin generation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 658.

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The impact of dabigatran on thrombin generation and other haemostatic markers after orthopaedic surgery. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 76). WILEY-BLACKWELL

Grimmett, C; Bridgewater, J; Steptoe, A; Wardle, J; (2011) Lifestyle and quality of life in colorectal cancer survivors. QUAL LIFE RES , 20 (8) 1237 - 1245. 10.1007/s11136-011-9855-1.

Groves, AM; Shastry, M; Rodriguez-Justo, M; Malhotra, A; Endozo, R; Davidson, T; Kelleher, T; (2011) F-18-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. EUR J NUCL MED MOL I , 38 (1) 46 - 52. 10.1007/s00259-010-1590-2.

Guerra, C; Collado, M; Navas, C; Schuhmacher, AJ; Hernández-Porras, I; Cañamero, M; Rodriguez-Justo, M; (2011) Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell , 19 (6) pp. 728-739. 10.1016/j.ccr.2011.05.011.

Gunaratnam, M; de la Fuente, M; Hampel, SM; Todd, AK; Reszka, AP; Schätzlein, A; Neidle, S; (2011) Targeting pancreatic cancer with a G-quadruplex ligand. Bioorg Med Chem , 19 (23) pp. 7151-7157. 10.1016/j.bmc.2011.09.055.

Guppy, A; Jamal-Hanjani, M; Pickering, L; (2011) Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. Future Oncol , 7 (6) pp. 727-736. 10.2217/fon.11.49.

Gutierrez, A; Grebliunaite, R; Feng, H; Kozakewich, E; Zhu, S; Guo, F; Payne, E; (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med , 208 (8) pp. 1595-1603. 10.1084/jem.20101691.

Gutierrez-Gonzalez, L; Graham, TA; Rodriguez-Justo, M; Leedham, SJ; Novelli, MR; Gay, LJ; Ventayol-Garcia, T; (2011) The Clonal Origins of Dysplasia From Intestinal Metaplasia in the Human Stomach. GASTROENTEROLOGY , 140 (4) 1251-+. 10.1053/j.gastro.2010.12.051.

Gómez-López, S; Wiskow, O; Favaro, R; Nicolis, SK; Price, DJ; Pollard, SM; Smith, A; (2011) Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitro. Glia , 59 (11) pp. 1588-1599. 10.1002/glia.21201.


Hackshaw, A; Kirkwood, A; (2011) Interpreting and reporting clinical trials with results of borderline significance. BMJ , 343 d3340-.

Hackshaw, A; Rodeck, C; Boniface, S; (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. HUM REPROD UPDATE , 17 (5) 589 - 604. 10.1093/humupd/dmr022. Gold open access

Hagerstrom, MN; Rorby, E; May, G; Tipping, A; Brown, J; Karlsson, G; Enver, T; (2011) Gata2 Is a Direct Target for Smad-Mediated TGF beta Signaling in Hematopoietic Stem/Progenitor Cells. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 580). AMER SOC HEMATOLOGY

Hall, A; Isgro, G; Morris, R; Burroughs, AK; Dhillon, AP; (2011) SIZE OF SAMPLE REQUIRED FOR DIGITAL IMAGE ANALYSIS MEASUREMENT OF LIVER COLLAGEN IN CIRRHOSIS. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S133-S133). ELSEVIER SCIENCE BV

Harding, J.; (2011) Small RNAs as regulators of early vertebrate development. Doctoral thesis, UCL (University College London). Green open access

Harrison, JD; Rodriguez-Justo, M; (2011) Commentary on IgG4-related sialadenitis: Mikulicz's disease, Küttner's tumour, and eponymy. Histopathology , 58 (7) pp. 1164-1166. 10.1111/j.1365-2559.2011.03824.x.

Harrison, P; Mackie, I; Mumford, A; Briggs, C; Liesner, R; Winter, M; Machin, S; (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. BRIT J HAEMATOL , 155 (1) 30 - 44. 10.1111/j.1365-2141.2011.08793.x.

Hart, DP; Skelton, S; Moss, DS; Sansom, CE; Gomez, K; Shepherd, AJ; (2011) Use of artificial neural networks for large scale prediction of factor VIII derived CD4 T cell epitopes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 930-931.

Hartig, N; Munoz-Alegre, M; Young, L; Rodriguez-Viciana, P; (2011) Role of R-Ras GTPases in the Wnt-Planar Cell Polarity pathway. In: (Proceedings) Annual Meeting of the American-Society-for-Cell-Biology (ASCB). AMER SOC CELL BIOLOGY

Hartley, JA; (2011) The development of pyrrolobenzodiazepines as antitumour agents. EXPERT OPIN INV DRUG , 20 (6) 733 - 744. 10.1517/13543784.2011.573477.

Hartley, JM; Spanswick, VJ; Hartley, JA; (2011) Measurement of DNA damage in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 731 pp. 309-320. 10.1007/978-1-61779-080-5_25.

Hartmann, S; Agostinelli, C; Klapper, W; Korkolopoulou, P; Koch, K; Marafioti, T; Piccaluga, PP; (2011) Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? HISTOPATHOLOGY , 59 (6) pp. 1173-1182. 10.1111/j.1365-2559.2011.04069.x.

Hayee, B; Antonopoulos, A; Murphy, EJ; Rahman, FZ; Sewell, G; Smith, BN; McCartney, S; (2011) G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. GLYCOBIOLOGY , 21 (7) 914 - 924. 10.1093/glycob/cwr023.

Haylock-Jacobs, S; Comerford, I; Bunting, M; Kara, E; Townley, S; Klingler-Hoffmann, M; Vanhaesebroeck, B; (2011) PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun , 36 (3-4) pp. 278-287. 10.1016/j.jaut.2011.02.006.

Hergovich, A; (2011) MOB control: Reviewing a conserved family of kinase regulators. CELL SIGNAL , 23 (9) 1433 - 1440. 10.1016/j.cellsig.2011.04.007.

Herzog, B; Pellet-Many, C; Britton, G; Hartzoulakis, B; Zachary, IC; (2011) VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Molecular Biology of the Cell , 22 (15) 2766 - 2776. 10.1091/mbc.E09-12-1061. Green open access

Herzog, RW; Davidoff, AM; Markusic, DM; Nathwani, AC; (2011) AAV Vector Biology in Primates: Finding the Missing Link? MOL THER , 19 (11) 1923 - 1924. 10.1038/mt.2011.218.


Hiwarkar, P; Shaw, BE; Tredger, JM; Brown, NW; Kulkarni, S; Saso, R; Evans, S; (2011) Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. CLIN TRANSPLANT , 25 (2) 222 - 227. 10.1111/j.1399-0012.2010.01226.x.

Hochdörfer, T; Kuhny, M; Zorn, CN; Hendriks, RW; Vanhaesebroeck, B; Bohnacker, T; Krystal, G; (2011) Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal , 23 (5) pp. 866-875. 10.1016/j.cellsig.2011.01.012.

Hollenbach, JA; Mack, SJ; Gourraud, P-A; Single, RM; Maiers, M; Middleton, D; Thomson, G; (2011) A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. TISSUE ANTIGENS , 78 (5) pp. 333-344. 10.1111/j.1399-0039.2011.01777.x.

Holme, H; Nanduri, V; (2011) Superior vena cava obstruction: dangers of a missed diagnosis. J Paediatr Child Health , 47 (3) pp. 150-151. 10.1111/j.1440-1754.2010.01741.x.

Hoorn, EJ; Walsh, SB; McCormick, JA; Furstenberg, A; Yang, CL; Roeschel, T; Paliege, A; (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. NAT MED , 17 (10) 1304 - U339. 10.1038/nm.2497.

Howie, AJ; (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) pp. 1197-1205. 10.1007/s00467-010-1701-0.

Hughes, D; (2011) Gaucher disease: hematologic and oncologic implications. Clin Adv Hematol Oncol , 9 (10) pp. 771-772.


Hughes, DA; Al-Sayed, M; Belmatoug, N; Bodamer, O; Bottcher, T; Cappellini, M; Cohen, IJ; (2011) Early access experience with VPRIV (R): Recommendations for 'core data' collection. BLOOD CELL MOL DIS , 47 (2) 140 - 142. 10.1016/j.bcmd.2010.10.015.

Hughes, DA; Romero, MAB; Hollak, CEM; Giugliani, R; Deegan, PB; FOS Investigators, ; (2011) Response of women with Fabry disease to enzyme replacement therapy: Comparison with men, using data from FOS-the Fabry Outcome Survey. MOL GENET METAB , 103 (3) 207 - 214. 10.1016/j.ymgme.2011.03.022.


Ibrahim, AR; Eliasson, L; Apperley, JF; Milojkovic, D; Bua, M; Szydlo, R; Mahon, F-X; (2011) Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. BLOOD , 117 (14) pp. 3733-3736. 10.1182/blood-2010-10-309807.

Isgro, G; Andreana, L; Garcovich, M; Luong, TV; Hall, A; Manousou, P; Goossens, N; (2011) COLLAGEN PROPORTIONATE AREA: BEST INDEX TO PREDICT DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIES. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S69-S70). ELSEVIER SCIENCE BV



JD, O; Adcock, DM; Ambrose Bush, T; de Moerloose, P; Gardiner, C; Ginyard, M; McMahan, CA; (2011) Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Clinical and Laboratory Standards Institute

Jamal-Hanjani, M; Pettengell, R; (2011) Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma. Expert Opin Drug Metab Toxicol , 7 (11) pp. 1441-1448. 10.1517/17425255.2011.618834.

Jennings, BH; (2011) Drosophila - a versatile model in biology & medicine. MATER TODAY , 14 (5) 190 - 195. Gold open access

Jiao, Y; Lawler, K; Patel, GS; Purushotham, A; Jones, AF; Grigoriadis, A; Tutt, A; (2011) DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference. BMC BIOINFORMATICS , 12 (ARTN 403) 10.1186/1471-2105-12-403. Gold open access

Johansson, AM; Hill, N; Perisoglou, M; Whelan, J; Karlsson, MO; Standing, JF; (2011) A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma. Therapeutic Drug Monitoring , 33 (6) pp. 711-718. 10.1097/FTD.0b013e31823615e1.

Juergens, H; Daw, NC; Geoerger, B; Ferrari, S; Villarroel, M; Aerts, I; Whelan, J; (2011) Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma. JOURNAL OF CLINICAL ONCOLOGY , 29 (34) pp. 4534-4540. 10.1200/JCO.2010.33.0670.


Kallinikou, K; Anjos-Afonso, F; Blundell, MP; Ings, SJ; Kassen, D; Thrasher, AJ; Linch, DC; (2011) CD26 Inhibition Can Aid the Homing of Cytokine Activated Mobilized Peripheral Blood (MPB)CD34+Cells to the Bone Marrow (BM) but a Ligand Dependent Attachment Defect Prevents Their Long Term Retention and Subsequent Engraftment. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 68). AMER SOC HEMATOLOGY

Kanga, U; McWhinnie, AJ; Mourya, M; Shaw, BE; Madrigal, JA; Mehra, NK; (2011) A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. TISSUE ANTIGENS , 77 (1) 85 - 87. 10.1111/j.1399-0039.2010.01562.x.

Kapoor, RR; Flanagan, SE; James, CT; McKiernan, J; Thomas, AM; Harmer, SC; Shield, JP; (2011) Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Diabetologia , 54 (10) pp. 2575-2583. 10.1007/s00125-011-2207-4. Green open access

Karwacz, K; Bricogne, C; MacDonald, D; Arce, F; Bennett, CL; Collins, M; Escors, D; (2011) PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8(+) T cells. EMBO MOL MED , 3 (10) 581 - 592. 10.1002/emmm.201100165. Gold open access

Kasperavičiute, D; Catarino, CB; Chinthapalli, K; Clayton, LMS; Thom, M; Martinian, L; Cohen, H; (2011) Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions. PLoS ONE , 6 (8) , Article e23182. 10.1371/journal.pone.0023182. Green open access

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2011) Deregulation of the bone marrow stromal compartment occurs early in multiple myeloma and precedes osteolytic bone disease. In: BONE. (pp. S253 - S254). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, PI; Yong, K; (2011) Mechanisms of osteoblast supression in multiple myeolma. In: BONE. (pp. S37 - S37). ELSEVIER SCIENCE INC

Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Meyer, T; Takei, M; (2011) CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. LIFE SCI , 89 (17-18) 603 - 608. 10.1016/j.lfs.2011.07.019.

Katodritou, E; Terpos, E; North, J; Kottaridis, P; Verrou, E; Gastari, V; Chadjiaggelidou, C; (2011) Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells. AMERICAN JOURNAL OF HEMATOLOGY , 86 (12) pp. 967-973. 10.1002/ajh.22163.

Keane, TM; Goodstadt, L; Danecek, P; White, MA; Wong, K; Yalcin, B; Heger, A; (2011) Mouse genomic variation and its effect on phenotypes and gene regulation. Nature , 477 (7364) pp. 289-294. 10.1038/nature10413.

Kepp, O; Galluzzi, L; Martins, I; Schlemmer, F; Adjemian, S; Michaud, M; Sukkurwala, AQ; (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev , 30 (1) pp. 61-69. 10.1007/s10555-011-9273-4.

Khan, AB; Lipman, M; Hopkins, S; Marshall, N; Galloway, M; Kibbler, C; (2011) Poor outcome of central nervous system invasive aspergillosis in HIV infection despite galactomannan-based diagnosis: A case series and literature review. Infectious Diseases in Clinical Practice , 19 (4) pp. 299-302. 10.1097/IPC.0b013e3182041769.

Khan, MS; El-Khouly, F; Davies, P; Toumpanakis, C; Caplin, ME; (2011) Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel). ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 34 (2) pp. 235-242. 10.1111/j.1365-2036.2011.04693.x.

Khan, MS; El-Khouly, F; Quigley, AM; Caplin, M; Toumpanakis, C; (2011) Y90-DOTATATE in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Survival following Different Indications for Treatment. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; El-Khouly, F; Toumpanakis, C; Meyer, T; Caplin, M; Luong, T; (2011) Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Garcia-Hernandez, J; Caplin, M; Meyer, T; (2011) Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs). In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Rashid, M; Rabouhans, JS; Yu, D; Tu, VL; Caplin, M; (2011) Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors. CLIN CANCER RES , 17 (2) 337 - 345. 10.1158/1078-0432.CCR-10-1776.

Khwaja, A; (2011) PI3K as a Target for Therapy in Haematological Malignancies. CURR TOP MICROBIOL , 347 169 - 188. 10.1007/82_2010_71.

Khwaja, A; Quinn, J; Yong, KL; (2011) The myeloma bone marrow environment and survival signaling. In: Myeloma: Pathology, Diagnosis, and Treatment. (pp. 64-83).

Kimata, Y; Kitamura, K; Fenner, N; Yamano, H; (2011) Mes1 controls the meiosis I to meiosis II transition by distinctly regulating the anaphase-promoting complex/cyclosome coactivators Fzr1/Mfr1 and Slp1 in fission yeast. MOL BIOL CELL , 22 (9) 1486 - 1494. 10.1091/mbc.E10-09-0774. Gold open access

King, RJ; Confer, DL; Greinix, HT; Halter, J; Horowitz, M; Schmidt, AH; Costeas, P; (2011) Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant , 46 (1) pp. 10-13. 10.1038/bmt.2010.37.

Kistler, AD; Siwy, J; Breunig, F; Jeevaratnam, P; Scherl, A; Mullen, W; Warnock, DG; (2011) A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy. PLOS ONE , 6 (6) , Article e20534. 10.1371/journal.pone.0020534. Green open access

Knowles, S; Cohen, H; (2011) The 2010 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Kocjan, G; Chandra, A; Cross, PA; Giles, T; Johnson, SJ; Stephenson, TJ; Roughton, M; (2011) The Interobserver Reproducibility of Thyroid Fine-Needle Aspiration Using the UK Royal College of Pathologists' Classification System. AM J CLIN PATHOL , 135 (6) 852 - 859. 10.1309/AJCPZ33MVMGZKEWU.

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. J Clin Oncol , 29 (18_suppl) LBA5006-.

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. J Clin Oncol , 29 (15_suppl) LBA5006-.

Kroemer, G; Adjemian, S; Michaud, M; Martins, I; Kepp, O; Sukkurwala, AQ; Menger, L; (2011) [Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]. Bull Mem Acad R Med Belg , 166 (3-4) pp. 130-138.

Kudsiova, L; Fridrich, B; Ho, J; Mustapa, MFM; Campbell, F; Welser, K; Keppler, M; (2011) Lipopolyplex Ternary Delivery Systems Incorporating C14 Glycerol-Based Lipids. MOL PHARMACEUT , 8 (5) 1831 - 1847. 10.1021/mp2001796.

Kudsiova, L; Ho, J; Fridrich, B; Harvey, R; Keppler, M; Ng, T; Hart, SL; (2011) Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection. MOL BIOSYST , 7 (2) 422 - 436. 10.1039/c0mb00149j.

Kulkarni, S; Sitaru, C; Jakus, Z; Anderson, KE; Damoulakis, G; Davidson, K; Hirose, M; (2011) PI3Kβ plays a critical role in neutrophil activation by immune complexes. Sci Signal , 4 (168) ra23-. 10.1126/scisignal.2001617.

Kumar, MS; Swanton, C; (2011) KRAS 3'-UTR variants and stratification of breast-cancer risk. Lancet Oncol , 12 (4) pp. 318-319. 10.1016/S1470-2045(11)70065-1.


Lafont, E; Kitatani, K; Okazaki, T; Ségui, B; (2011) Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies. Recent Pat Anticancer Drug Discov , 6 (3) pp. 324-333.

Lambrianides, A; Turner-Stokes, T; Pericleous, C; Ehsanullah, J; Papadimitraki, E; Poulton, K; Ioannou, Y; (2011) Interactions of Human Monoclonal and Polyclonal Antiphospholipid Antibodies With Serine Proteases Involved in Hemostasis. ARTHRITIS AND RHEUMATISM , 63 (11) pp. 3512-3521. 10.1002/art.30525.

Larkin, J; Swanton, C; Pickering, L; (2011) Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action. Expert Rev Anticancer Ther , 11 (4) pp. 639-649. 10.1586/era.11.21.

Lawley, S; Cohen, H; Pavord, S; Fitzmaurice, D; (2011) Dragons den on oral anticoagulants for atrial fibrillation. Presented at: British society for haematology annual scientific meeting, Brighton.

Lawrenson, K; Sproul, D; Grun, B; Notaridou, M; Benjamin, E; Jacobs, IJ; Dafou, D; (2011) Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. CARCINOGENESIS , 32 (10) pp. 1540-1549. 10.1093/carcin/bgr140.

Lawrie, AS; Canciani, MT; Iseppi, J; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) High throughput detection of von Willebrand's disease using a new coagulation analyser. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 672.

Lawrie, AS; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) Evaluation of an automated platelet-based assay of ristocetin cofactor activity. HAEMOPHILIA , 17 (2) 252 - 256. 10.1111/j.1365-2516.2010.02419.x.

Lawson, AR; Hindley, GF; Forshew, T; Tatevossian, RG; Jamie, GA; Kelly, GP; Neale, GA; (2011) RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. Genome Res , 21 (4) pp. 505-514. 10.1101/gr.115782.110.

Ledermann, JA; (2011) Benefits of Enhancing the Platinum-Free Interval in the Treatment of Relapsed Ovarian Cancer More Than Just a Hypothesis? INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 21 S9 - S11. 10.1097/IGC.0b013e318217b30b.

Ledermann, JA; Hackshaw, A; Kaye, S; Jayson, G; Gabra, H; McNeish, I; Earl, H; (2011) Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer. J CLIN ONCOL , 29 (28) 3798 - 3804. 10.1200/JCO.2010.33.5208.

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, IB; Rustin, GJ; Scott, C; (2011) Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). J Clin Oncol , 29 (15_suppl) 5003-.

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, IB; Rustin, GJS; Scott, C; (2011) Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Ledermann, JA; Marth, C; Carey, MS; Birrer, M; Bowtell, DDL; Kaye, S; McNeish, I; (2011) Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer. INT J GYNECOL CANCER , 21 (4) 763 - 770. 10.1097/IGC.0b013e31821b2669.

Ledermann, JA; Raja, FA; (2011) Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. EUROPEAN JOURNAL OF CANCER , 47 S104-S115.

Lee, AJ; Endesfelder, D; Rowan, AJ; Walther, A; Birkbak, NJ; Futreal, PA; Downward, J; (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res , 71 (5) pp. 1858-1870. 10.1158/0008-5472.CAN-10-3604.

Leoni, LM; Hartley, JA; (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. SEMIN HEMATOL , 48 (2) S12 - S23. 10.1053/j.seminhematol.2011.03.003.

Li, Q; Birkbak, NJ; Gyorffy, B; Szallasi, Z; Eklund, AC; (2011) Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics , 12 474-. 10.1186/1471-2105-12-474.

Li, Q; Eklund, AC; Birkbak, NJ; Desmedt, C; Haibe-Kains, B; Sotiriou, C; Symmans, WF; (2011) Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response. BMC Bioinformatics , 12 310-. 10.1186/1471-2105-12-310.

Liccardi, G; Hartley, JA; Hochhauser, D; (2011) EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. CANCER RES , 71 (3) 1103 - 1114. 10.1158/0008-5472.CAN-10-2384. Gold open access

Lin, S; Kiakos, K; Lee, M; Hochhauser, D; Hartley, JA; (2011) Targeting the Mlul cell cycle box (MCB) sequence 5 '-ACGCGT-3 ' in the human Dbf4 promoter using the rationally designed polyamide formamido-imidazole-pyrrole-imidazole (f-IPI). CANCER RESEARCH , 71 10.1158/1538-7445.AM2011-665.

Lindblad-Toh, K; Garber, M; Zuk, O; Lin, MF; Parker, BJ; Washietl, S; Kheradpour, P; (2011) A high-resolution map of human evolutionary constraint using 29 mammals. NATURE , 478 (7370) pp. 476-482. 10.1038/nature10530.

Linthorst, GE; Germain, DP; Hollak, CEM; Hughes, D; Rolfs, A; Wanner, C; Mehta, A; (2011) Expert opinion on temporary treatment recommendations for Fabry the disease during the shortage of enzyme replacement therapy (ERT). MOL GENET METAB , 102 (1) 99 - 102. 10.1016/j.ymgme.2010.11.155.

Liu, H; Wang, W; Chew, SK; Lee, SC; Li, J; Vassiliou, GS; Green, T; (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) pp. 689-695. 10.1002/dvg.20741.

Lobo, C; McQueen, A; Beale, T; Kocjan, G; (2011) The UK Royal College of Pathologists Thyroid Fine-Needle Aspiration Diagnostic Classification Is a Robust Tool for the Clinical Management of Abnormal Thyroid Nodules. ACTA CYTOLOGICA , 55 (6) pp. 499-506. 10.1159/000333234.

Locke, DP; Hillier, LW; Warren, WC; Worley, KC; Nazareth, LV; Muzny, DM; Yang, SP; (2011) Comparative and demographic analysis of orang-utan genomes. Nature , 469 (7331) pp. 529-533. 10.1038/nature09687.

Lolkema, MP; Arkenau, HT; Harrington, K; Roxburgh, P; Morrison, R; Roulstone, V; Twigger, K; (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res , 17 (3) pp. 581-588. 10.1158/1078-0432.CCR-10-2159.

Lopez, MN; Pesce, B; Kurte, M; Perez, C; Segal, G; Roa, J; Aguillon, JC; (2011) A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-beta plus tolerogenic dendritic cells. IMMUNOBIOLOGY , 216 (10) 1117 - 1126. 10.1016/j.imbio.2011.04.006.

Lotta, LA; Wu, HM; Mackie, IJ; Noris, M; Veyradier, A; Machin, SJ; Remuzzi, G; (2011) Residual plasmatic activity of ADAMTS13 in congenital thrombotic thrombocytopenic purpura and its correlation with disease phenotype. J THROMB HAEMOST , 9 26 - 27.

Louis, CU; Savoldo, B; Dotti, G; Pule, M; Yvon, E; Myers, GD; Rossig, C; (2011) Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood , 118 (23) pp. 6050-6056. 10.1182/blood-2011-05-354449.

Lowry, L; Smith, P; Qian, W; Falk, S; Benstead, K; Illidge, T; Linch, D; (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol , 100 (1) pp. 86-92. 10.1016/j.radonc.2011.05.013.

Luc, S; Macaulay, IC; Buza-Vidas, N; Bouriez-Jones, T; Lutteropp, M; Woll, P; Mead, AJ; (2011) The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1011). AMER SOC HEMATOLOGY



Mackie, I; Eapen, CE; Neil, D; Lawrie, AS; Chitolie, A; Shaw, JC; Elias, E; (2011) Idiopathic Noncirrhotic Intrahepatic Portal Hypertension is Associated with Sustained ADAMTS13 Deficiency. DIGEST DIS SCI , 56 (8) 2456 - 2465. 10.1007/s10620-011-1729-4.

Mackie, IJ; Chitolie, A; Westwood, JP; Lawrie, A; Carr, P; Liesner, R; Cohen, H; (2011) Antibodies against prothrombin/phosphatidyl serine in thrombosis an pregnancy morbidity. In: (Proceedings) VII European Forum on antiphospholipid antibodies.

Mackinnon, S; Chakraverty, R; (2011) Families get mobilized to treat AML. BLOOD , 117 (3) 746 - 748. 10.1182/blood-2010-11-315929.

Maggio, A; Filosa, A; Vitrano, A; Aloj, G; Kattamis, A; Ceci, A; Fucharoen, S; (2011) Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials. BLOOD CELLS MOLECULES AND DISEASES , 47 (3) pp. 166-175. 10.1016/j.bcmd.2011.07.002.

Mahadevan, D; Plummer, R; Squires, MS; Rensvold, D; Kurtin, S; Pretzinger, C; Dragovich, T; (2011) A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. ANN ONCOL , 22 (9) 2137 - 2143. 10.1093/annonc/mdq734.

Manchanda, R; Abdelraheim, A; Johnson, M; Rosenthal, AN; Benjamin, E; Brunell, C; Burnell, M; (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG-INT J OBSTET GY , 118 (7) 814 - 824. 10.1111/j.1471-0528.2011.02920.x.

Mandeville, H.C.; (2011) Exploration of the clinical interaction between vascular targeting agents and radiotherapy. Doctoral thesis, UCL (University College London). Green open access

Manousou, P; Dhillon, AP; Isgro, G; Calvaruso, V; Luong, TV; Tsochatzis, E; Xirouchakis, E; (2011) Digital Image Analysis of Liver Collagen Predicts Clinical Outcome of Recurrent Hepatitis C Virus 1 Year After Liver Transplantation. LIVER TRANSPLANT , 17 (2) 178 - 188. 10.1002/lt.22209.

Manousou, P; Kalambokis, G; Grillo, F; Watkins, J; Xirouchakis, E; Pleguezuelo, M; Leandro, G; (2011) Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. LIVER INT , 31 (5) 730 - 739. 10.1111/j.1478-3231.2011.02488.x.

Mansour, MR; Look, AT; (2011) Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma. CANCER CELL , 20 (5) pp. 559-561. 10.1016/j.ccr.2011.10.027.

Mansur, A; Little, MA; Oh, WC; Jacques, S; Nightingale, P; Howie, AJ; Savage, COS; (2011) Immune Profile and Epstein-Barr Virus Infection in Acute Interstitial Nephritis: An Immunohistochemical Study in 78 Patients. NEPHRON CLINICAL PRACTICE , 119 (4) C293-C300. 10.1159/000329671.

Markert, ML; Marques, JG; Neven, B; Devlin, BH; McCarthy, EA; Chinn, IK; Albuquerque, AS; (2011) First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. Blood , 117 (2) pp. 688-696. 10.1182/blood-2010-06-292490.

Marsh, D; Suchak, K; Moutasim, KA; Vallath, S; Hopper, C; Jerjes, W; Upile, T; (2011) Stromal features are predictive of disease mortality in oral cancer patients. J PATHOL , 223 (4) 470 - 481. 10.1002/path.2830.

Marsh, D.J.; (2011) The αvβ6 Integrin in cancer. Doctoral thesis, UCL (University College London). Green open access

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update April 2011. TISSUE ANTIGENS , 78 (4) pp. 299-306. 10.1111/j.1399-0039.2011.01758.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2010. TISSUE ANTIGENS , 77 (2) pp. 167-175. 10.1111/j.1399-0039.2010.01595.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2011. TISSUE ANTIGENS , 78 (6) pp. 474-481. 10.1111/j.1399-0039.2011.01792.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update December 2010. TISSUE ANTIGENS , 77 (4) pp. 362-363. 10.1111/j.1399-0039.2011.01642.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update February 2011. TISSUE ANTIGENS , 77 (6) pp. 613-617. 10.1111/j.1399-0039.2011.01688.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update January 2011. TISSUE ANTIGENS , 77 (6) pp. 603-612. 10.1111/j.1399-0039.2011.01687.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2010. TISSUE ANTIGENS , 77 (2) pp. 162-166. 10.1111/j.1399-0039.2010.01594.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2011. TISSUE ANTIGENS , 78 (6) pp. 468-473. 10.1111/j.1399-0039.2011.01790.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update June 2011. TISSUE ANTIGENS , 78 (4) pp. 314-319. 10.1111/j.1399-0039.2011.01760.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update March 2011. TISSUE ANTIGENS , 78 (1) pp. 77-79. 10.1111/j.1399-0039.2011.01696.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update May 2011. TISSUE ANTIGENS , 78 (4) pp. 307-313. 10.1111/j.1399-0039.2011.01759.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update November 2010. TISSUE ANTIGENS , 77 (4) pp. 355-361. 10.1111/j.1399-0039.2011.01643.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update October 2010. TISSUE ANTIGENS , 77 (4) pp. 349-354. 10.1111/j.1399-0039.2011.01644.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2010. TISSUE ANTIGENS , 77 (3) pp. 268-270. 10.1111/j.1399-0039.2010.01604.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2011. TISSUE ANTIGENS , 78 (6) pp. 482-484. 10.1111/j.1399-0039.2011.01797.x.

Martins, I; Kepp, O; Schlemmer, F; Adjemian, S; Tailler, M; Shen, S; Michaud, M; (2011) Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene , 30 (10) pp. 1147-1158. 10.1038/onc.2010.500.

Masir, N; Jones, M; Marafioti, T; Mason, DY; (2011) Heterogeneous expression of B cell-associated markers in follicular lymphoma. Histopathology , 58 (4) pp. 633-636. 10.1111/j.1365-2559.2011.03782.x.

Mattar, CNZ; Nathwani, AC; Waddington, SN; Dighe, N; Kaeppel, C; Nowrouzi, A; Mcintosh, J; (2011) Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques. MOL THER , 19 (11) 1950 - 1960. 10.1038/mt.2011.107.

Maughan, T; Wilson, RH; Williams, GT; Seymour, MT; Richman, S; Quirke, P; Pope, M; (2011) Developing a biomarker-stratified trial design in advanced colorectal cancer: The MRC FOCUS 3 feasibility study. J Clin Oncol , 29 (15_suppl) TPS165-.

Maughan, TS; Adams, RA; Smith, CG; Meade, AM; Seymour, MT; Wilson, RH; Idziaszczyk, S; (2011) Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet , 377 (9783) pp. 2103-2114. 10.1016/S0140-6736(11)60613-2.

Maybin, JA; Battersby, S; Hirani, N; Nikitenko, LL; Critchley, HOD; Jabbour, HN; (2011) The Expression and Regulation of Adrenomedullin in the Human Endometrium: A Candidate for Endometrial Repair. ENDOCRINOLOGY , 152 (7) pp. 2845-2856. 10.1210/en.2010-1256.

McCaughan, F; Pipinikas, CP; Janes, SM; George, PJ; Rabbitts, PH; Dear, PH; (2011) Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia. J PATHOL , 224 (2) 153 - 159. 10.1002/path.2887.

McDonald, V; Pizzey, A; Machin, SJ; Scully, MA; (2011) The development of acute idiopathic TTP is not associated with changes in T cell or T-regulatory cell numbers. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 915-916.

Melichar, B; Casado, E; Bridgewater, J; Bennouna, J; Campone, M; Vitek, P; Delord, J-P; (2011) Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial. BRITISH JOURNAL OF CANCER , 105 (11) pp. 1646-1653. 10.1038/bjc.2011.438.

Mellars, G; Gomez, K; (2011) Mutation detection by Southern blotting. Methods Mol Biol , 688 pp. 281-291. 10.1007/978-1-60761-947-5_19.

Mendoza-Naranjo, A; Bouma, G; Pereda, C; Ramirez, M; Webb, KF; Tittarelli, A; Lopez, MN; (2011) Functional Gap Junctions Accumulate at the Immunological Synapse and Contribute to T Cell Activation. J IMMUNOL , 187 (6) 3121 - 3132. 10.4049/jimmunol.1100378.

Menezes, LJ; Kotze, CW; Agu, O; Richards, T; Brookes, J; Goh, VJ; Rodriguez-Justo, M; (2011) Investigating Vulnerable Atheroma Using Combined F-18-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation. J NUCL MED , 52 (11) 1698 - 1703. 10.2967/jnumed.111.093724.

Meyer, C; Sevko, A; Ramacher, M; Bazhin, AV; Falk, CS; Osen, W; Borrello, I; (2011) Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A , 108 (41) pp. 17111-17116. 10.1073/pnas.1108121108.

Michaud, M; Martins, I; Sukkurwala, AQ; Adjemian, S; Ma, Y; Pellegatti, P; Shen, S; (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science , 334 (6062) pp. 1573-1577. 10.1126/science.1208347.

Middleton, GW; Gwyther, SJ; Brown, SR; Maughan, T; Olivier, C; Richman, S; Maisey, NR; (2011) Biomodulation of irinotecan using ciclosporin: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC). J Clin Oncol , 29 (15_suppl) 3566-.

Milojkovic, D; Apperley, JF; Ibrahim, AR; Bua, M; Reid, A; Gerrard, G; Foroni, L; (2011) Prolonged Survival Following Imatinib Failure for CML Patients in CP May Require Multiple TKI Strategies for Responding Patients. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 1613-1614). AMER SOC HEMATOLOGY

Milojkovic, D; Gerrard, G; Paliompeis, C; Bua, M; Reid, A; Alikian, M; Khorashad, J; (2011) The Natural History of RTQ-PCR Levels After the Achievement of Complete Molecular Remission (CMR): Implications for 'Stopping' Studies. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 278). AMER SOC HEMATOLOGY

Milojkovic, D; Ibrahim, AR; Foroni, L; Lucas, C; Gerrard, G; Wang, L; Szydlo, RM; (2011) Assessment of BCR-ABL1 Transcript Levels At 3 Months Is the Only Requirement for Predicting Outcome for Patients with Chronic Myeloid Leukemia Treated with Imatinib. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 729). AMER SOC HEMATOLOGY

Mindell, J; Aresu, M; Zaninotto, P; Falaschetti, E; Poulter, N; (2011) Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey-2006. Clinical Endocrinology , 75 (5) 621 - 627. 10.1111/j.1365-2265.2011.04094.x. Green open access

Mitchison, NA; Bhattacharya, S; Tuddenham, EGD; (2011) Human Congenital Diseases with Mixed Modes of Inheritance Have a Shortage of Recessive Disease. A Demographic Scenario? ANN HUM GENET , 75 688 - 693. 10.1111/j.1469-1809.2011.00679.x.

Mohamedbhai, SG; Sibson, K; Marafioti, T; Kayani, I; Lowry, L; Goldstone, AH; Linch, DC; (2011) Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index > 95%. BRIT J HAEMATOL , 152 (2) 175 - 181. 10.1111/j.1365-2141.2010.08447.x.

Mohammed, K; Dignan, F; Ethell, ME; Davies, FE; Morgan, GJ; Riley, U; Evans, S; (2011) An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. LEUKEMIA LYMPHOMA , 52 (2) 339 - 340. 10.3109/10428194.2010.527407.

Moiseeva, VS; Motovilov, KA; Lobysheva, NV; Orlov, VN; Yaguzhinsky, LS; (2011) The formation of metastable bond between protons and mitoplast surface. Dokl Biochem Biophys , 438 pp. 127-130. 10.1134/S1607672911030069.


Morris, C; Cook, G; Streetly, M; Kettle, P; Drake, M; Quinn, M; Cavet, J; (2011) Re-transplantation after bortezomib-based therapy. BRITISH JOURNAL OF HAEMATOLOGY , 153 (5) pp. 666-668. 10.1111/j.1365-2141.2010.08521.x.

Morris, CR; Kim, HY; Trachtenberg, F; Wood, J; Quinn, CT; Sweeters, N; Kwiatkowski, JL; (2011) Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. BLOOD , 118 (14) 3794 - 3802. 10.1182/blood-2010-11-319152.

Myers, RM; Stamatoyannopoulos, J; Snyder, M; Dunham, I; Hardison, RC; Bernstein, BE; Gingeras, TR; (2011) A user's guide to the Encyclopedia of DNA elements (ENCODE). PLoS Biology , 9 (4) , Article e1001046. 10.1371/journal.pbio.1001046. Green open access


Naqvi, N; Davidson, SJ; Wong, D; Cullinan, P; Roughton, M; Doughty, VL; Franklin, RC; (2011) Predicting 22q11.2 deletion syndrome: a novel method using the routine full blood count. Int J Cardiol , 150 (1) pp. 50-53. 10.1016/j.ijcard.2010.02.027.

Nathwani, AC; Rosales, C; McIntosh, J; Rastegarlari, G; Nathwani, D; Raj, D; Nawathe, S; (2011) Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins. MOL THER , 19 (5) 876 - 885. 10.1038/mt.2010.274.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, J; Linch, DC; Chowdary, P; (2011) Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B. NEW ENGLAND JOURNAL OF MEDICINE , 365 (25) pp. 2357-2365. 10.1056/NEJMoa1108046.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, JH; Linch, DC; Chowdary, P; (2011) Adeno-Associated Viral Vector Mediated Gene Transfer for Hemophilia B. BLOOD , 118 (21) pp. 4-5.

Navani, N; Booth, HL; Kocjan, G; Falzon, M; Capitanio, A; Brown, JM; Porter, JC; (2011) Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis. RESPIROLOGY , 16 (3) 467 - 472. 10.1111/j.1440-1843.2011.01933.x.

Navani, N; Nankivell, M; Nadarajan, P; Pereira, SP; Kocjan, G; Janes, SM; (2011) The learning curve for EBUS-TBNA. THORAX , 66 (4) 352 - 353. 10.1136/thx.2010.146407.

Navani, N; Nankivell, M; Woolhouse, I; Harrison, RN; Munavvar, M; Oltmanns, U; Falzon, M; (2011) Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Intrathoracic Lymphadenopathy in Patients with Extrathoracic Malignancy A Multicenter Study. J THORAC ONCOL , 6 (9) 1505 - 1509. 10.1097/JTO.0b013e318223c3fe.

Neufeld, EJ; Galanello, R; Viprakasit, V; Aydinok, Y; Piga, A; Harmatz, P; Forni, GL; (2011) Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 315-316). AMER SOC HEMATOLOGY

Nicholson, E; Mackinnon, S; (2011) Relapsed AML post-allogeneic hematopoietic stem cell transplantation. Clin Adv Hematol Oncol , 9 (12) pp. 951-955.

Nicolaides, TP; Li, H; Solomon, DA; Hariono, S; Hashizume, R; Barkovich, K; Baker, SJ; (2011) Targeted therapy for BRAFV600E malignant astrocytoma. Clin Cancer Res , 17 (24) pp. 7595-7604. 10.1158/1078-0432.CCR-11-1456.

Nolte, F; Angelucci, E; Beris, P; Macwhannell, A; Selleslag, D; Schumann, C; Xicoy, B; (2011) Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox. Leuk Res , 35 (9) pp. 1131-1135. 10.1016/j.leukres.2011.06.013.


O'Mahony, C; Coats, C; Cardona, M; Garcia, A; Calcagnino, M; Murphy, E; Lachmann, R; (2011) Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. Europace , 13 (12) pp. 1781-1788. 10.1093/europace/eur267.

Osawa, T; Davies, D; Hartley, JA; (2011) Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells. CELL DEATH DIS , 2 , Article e187. 10.1038/cddis.2011.70. Gold open access


Pacey, S; Wilson, RH; Walton, M; Eatock, MM; Hardcastle, A; Zetterlund, A; Arkenau, HT; (2011) A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res , 17 (6) pp. 1561-1570. 10.1158/1078-0432.CCR-10-1927.

Partridge, L; Alic, N; Bjedov, I; Piper, MDW; (2011) Ageing in Drosophila: The role of the insulin/Igf and TOR signalling network. Experimental Gerontology , 46 (5) 376 - 381. 10.1016/j.exger.2010.09.003. Green open access

Patel, B; Dey, A; Ghorani, E; Kumar, S; Malam, Y; Rai, L; Steele, AJ; (2011) Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights. MOL THER , 19 (6) 1034 - 1040. 10.1038/mt.2011.44.

Paul, DS; Nisbet, JP; Yang, TP; Meacham, S; Rendon, A; Hautaviita, K; Tallila, J; (2011) Maps of open chromatin guide the functional follow-up of genome-wide association signals: application to hematological traits. PLoS Genet , 7 (6) , Article e1002139. 10.1371/journal.pgen.1002139. Green open access

Payne, EM; Bolli, N; Rhodes, J; Abdel-Wahab, OI; Levine, R; Hedvat, CV; Stone, R; (2011) Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. BLOOD , 118 (4) pp. 903-915. 10.1182/blood-2010-11-318022.

Peggs, KS; (2011) Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies. EXPERT REVIEW OF ANTICANCER THERAPY , 11 (11) pp. 1667-1670. 10.1586/ERA.11.159.

Peggs, KS; Kayani, I; Edwards, N; Kottaridis, P; Goldstone, AH; Linch, DC; Hough, R; (2011) Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell-Depleted Allogeneic Transplantation for Hodgkin's Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , 29 (8) 971 - 978. 10.1200/JCO.2010.32.1711.

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Chakraverty, R; Pang, K; (2011) Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation. CLIN INFECT DIS , 52 (1) 49 - 57. 10.1093/cid/ciq042.

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; (2011) Continued improvement in myocardial T2(star) over two years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload. Haematologica - The Hematology Journal , 96 (1) 48 - 54. 10.3324/haematol.2010.031468. Green open access

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; (2011) Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload. Haematologica , 96 (1) pp. 48-54. 10.3324/haematol.2010.031468.

Perren, TJ; Swart, AM; Pfisterer, J; Ledermann, JA; Pujade-Lauraine, E; Kristensen, G; Carey, MS; (2011) A Phase 3 Trial of Bevacizumab in Ovarian Cancer. NEW ENGLAND JOURNAL OF MEDICINE , 365 (26) pp. 2484-2496. 10.1056/NEJMoa1103799.

Pillay, N; Amary, FM; Berisha, F; Tirabosco, R; Flanagan, AM; (2011) P63 does not regulate brachyury expression in human chordomas and osteosarcomas. HISTOPATHOLOGY , 59 (5) pp. 1025-1027. 10.1111/j.1365-2559.2011.03973.x.

Pitt, K; James, C; Kochar, IS; Kapoor, A; Jain, S; Hussain, K; Bennett, K; (2011) A single base-pair deletion in the WFS1 gene causes Wolfram syndrome. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , 24 (5-6) pp. 389-391. 10.1515/JPEM.2011.215.

Plummer, R; Wilson, RH; Calvert, H; Boddy, AV; Griffin, M; Sludden, J; Tilby, MJ;